These are JPMorgan’s top drug picks heading into earnings.
This under-the-radar drug stock is undergoing a long-term turnaround, according to the charts
Katie Stockton breaks down the charts on Viatris.
A movie theater chain you’ve likely never heard of is a catch-up trade, according to Benchmark
The firm said shares can rally more than 45% after sliding this year.
Investors are punishing stocks that miss earnings more than normal this season
The market is rewarding positive earnings surprises less than average and punishing negative surprises more than usual, according to FactSet.
JPMorgan thinks this emerging home appliance company with a wacky name is cheap going in to earnings
This stock is trading below fair value despite its much stronger growth outlook and margin structure versus peers, according to JPMorgan.
Coinbase could be ready to achieve a mainstream milestone that boosts the stock, predicts Oppenheimer
Blockchain development in the U.S. is reaching a “monumental turning point,” Oppenhimer said.
Morgan Stanley’s auto analyst Jonas names Tesla his top pick, sees 40% upside
Tesla is successfully cutting costs and is exposed to notable growth drivers for the future, according to the analyst.
Here are Monday’s biggest analyst calls: Nvidia, Apple, Tesla, Live Nation, 3M, Uber, Eli Lilly, Amazon, Coinbase & more
Here are Monday’s biggest calls on Wall Street.
Monday’s analyst calls: Apple price target hike ahead of earnings, cloud stock gets an upgrade
Two tech companies were among the names being talked about by analysts on Monday.
Top Wall Street analysts suggest these dividend stocks for enhanced returns
TipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Coca-Cola and Diamondback Energy